Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life, reflects on the impact COVID has had on our understanding that, as a society, we are only as safe as the least protected member in our global community. He emphasizes the need to diagnose pre-symptomatic and symptomatic conditions and the long-term value of advanced diagnostics to address individual and population health needs.

Rakesh elaborates, "It's leveraging the latest science, shortening the preclinical latency gap between new diagnostic tests, which we know are scientifically impactful. Yet, it takes 10 to 15 years to become embedded in mainstream clinical practice. Fast-forwarding those things, curating them in a thoughtful manner so that not everybody gets the same suite of tests, but they're actually tailored for age, gender, and other types of, what we say, comorbidities or other sorts of things that are going on in people's lives."

"We understand, through our decades of research, that fixing the heart valve, if it's leaking, it’s way too late. The heart never recovers despite the fact that they now have a normal heart valve. The same is true with any disease process in the body. If we wait until a disease manifests itself symptomatically, with symptoms, whether it's a heart attack or metastatic cancer or dementia or osteoarthritis, debilitating or arthritic conditions, we know that we oftentimes can never restore a normal human performance and normal human healthspan."

#FountainLife #PreventativeMedicine #PrecisionMedicine #EarlyDetection #FunctionalHealth #ProactiveCare #Healthcare #DiseasePrevention #Longevity #Healthspan

FountainLife.com

Download the transcript here

Translating the HR Digital Revolution to Everyday Work